Source: Investing Published 02/19/2025, 04:05
Cathy Wood’s ARK Fund posted its daily trades on Tuesday, February 18, 2025, showing a continued focus on the biotechnology sector. The largest trade of the day was a purchase of 60,227 shares of Twist Bioscience Corp (NASDAQ:TWST), for a total value of $2,866,202. The move signals ARK’s growing interest in the gene sequencing company, following a pattern of continued buying, including adding 82,632 shares the previous week.
In addition to Twist Bioscience, ARK increased its stake in Beam Therapeutics Inc (NASDAQ:BEAM) by acquiring a combined 47,127 shares via its ARKK and ARKG ETFs, valued at $1,526,914. This deal continues a trend seen over the past week, with ARK previously buying 70,612 shares on Thursday and 19.16 shares on Friday, indicating a positive outlook for the gene-editing company.
Another notable deal was the purchase of 9,021 shares of Ibotta Inc (NYSE:IBTA) via its ARKF ETF, for a total value of $666,561. This follows a larger purchase of the same stock on Friday, indicating ARK’s increased confidence in the mobile technology company.
ARK’s continued investments in these companies underscores its strategic focus on innovative and disruptive technologies, particularly in the biotech and genomics sectors. Investors following Cathy Wood’s ARK funds are seeing a clear pattern of investing heavily in growth-oriented companies in these evolving sectors.
While the focus remains on these large deals, ARK’s daily report also reflects a series of smaller transactions that contribute to the ETF’s overall investment strategy. As ARK continues to adjust its portfolio, investors are provided with insights into the evolving landscape of technological advancements and the funds’ positions in the companies driving these changes.
